Clinical trial
Candesartan's Effects on Alzheimer's Disease And Related Biomarkers
NCT02646982 is registered in ClinicalTrials.gov with Emory University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Candesartan's Effects on Alzheimer's Disease And Related Biomarkers
- Lead sponsor
- Emory University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2016
- Completion date
- August 17, 2020
- Enrollment
- 77 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
mild cognitive impairment